The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins

被引:54
作者
Hamed, SA
Nabeshima, T
机构
[1] Assiut Univ Hosp, Dept Neurol, Assiut, Egypt
[2] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol, Nagoya, Aichi 4668560, Japan
[3] Nagoya Univ, Grad Sch Med, Hosp Pharm, Nagoya, Aichi 4668560, Japan
关键词
atherosclerosis; epilepsy; homocysteine; oxidative stress; multivitamin;
D O I
10.1254/jphs.CRJ05003X
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Neurologists have little concern about the high atherosclerotic risk among epileptics. Recent evidences mount that chronic epilepsy and prolonged use of antiepileptic drugs (AEDs) are associated with multiple risk factors that are critically implicated in pathobiology and dysfunction of the vessel wall through complex molecular mechanisms that promote atherogenesis. This review is concerned with three metabolic alterations, which are attributed as major risk factors for atherosclerosis among epileptics: altered metabolism of a) homocysteine (Hey), b) lipids and lipoproteins, and c) uric acid. Most conventional AEDs reduce folic acid levels, thereby raising Hey levels. Hyperhomosysteinemia is recently believed to induce endothelial dysfunction and promote atherosclerosis through complex oxidative and excitatory neurotoxic molecular mechanisms. However, Hey itself is a convulsing substance with increased seizure recurrence and intractability to antiepileptic medications. AEDs can disturb lipid metabolism with resultant hypercholestrolemia and dyslipidemia, common recognized risks for atherosclerosis. Altered uric acid metabolism is common among epileptics. Uric acid has been implicated in endothelial cell damage and decreased endothelial nitric oxide bioavailability. In the presence of atherosclerotic milieu, uric acid interacts with other substrate toxicities and increased reactive oxygen species, accelerating atherosclerosis. The above information forms the rationale for future routine screening and correction or such metabolic alterations in epileptics. A convincing argument now develops that routine polyvitamin supplementation (folic acid, vitamin B12, vitamin B6, vitamin C, vitamin E, and beta-carotene) becomes increasingly important for women and men receiving AEDs at all ages. The atheroprotective effect of multivitamins is through their antioxidant and anti-inflammatory effects together with their lipid and Hey lowering effects.
引用
收藏
页码:340 / 353
页数:14
相关论文
共 164 条
[2]
Serum and hair zinc levels in epileptic children taking valproic acid [J].
Altunbasak, S ;
Biatmakoui, F ;
Baytok, V ;
Herguner, O ;
Burgut, HR ;
Kayrin, L .
BIOLOGICAL TRACE ELEMENT RESEARCH, 1997, 58 (1-2) :117-125
[3]
HEART-DISEASE MORTALITY AND MORBIDITY IN PATIENTS WITH EPILEPSY [J].
ANNEGERS, JF ;
HAUSER, WA ;
SHIRTS, SB .
EPILEPSIA, 1984, 25 (06) :699-704
[4]
The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs [J].
Apeland, T ;
Mansoor, MA ;
Pentieva, K ;
McNulty, H ;
Seljeflot, I ;
Strandjord, RE .
EPILEPSY RESEARCH, 2002, 51 (03) :237-247
[5]
Antiepileptic drugs as independent predictors of plasma total homocysteine levels [J].
Apeland, T ;
Mansoor, MA ;
Strandjord, RE .
EPILEPSY RESEARCH, 2001, 47 (1-2) :27-35
[6]
Homocysteine concentrations and methionine loading in patients on antiepileptic drugs [J].
Apeland, T ;
Mansoor, MA ;
Strandjord, RE ;
Kristensen, O .
ACTA NEUROLOGICA SCANDINAVICA, 2000, 101 (04) :217-223
[7]
Copper-homocysteine complexes and potential physiological actions [J].
Apostolova, MD ;
Bontchev, PR ;
Ivanova, BB ;
Russell, WR ;
Mehandjiev, DR ;
Beattie, JH ;
Nachev, CK .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2003, 95 (04) :321-333
[8]
Artenie R, 2003, Rev Med Chir Soc Med Nat Iasi, V107, P282
[9]
HDL cholesterol and protective factors in atherosclerosis [J].
Assmann, G ;
Gotto, AM .
CIRCULATION, 2004, 109 (23) :8-14
[10]
When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid [J].
Bagnati, M ;
Perugini, C ;
Cau, C ;
Bordone, R ;
Albano, E ;
Bellomo, G .
BIOCHEMICAL JOURNAL, 1999, 340 :143-152